Luiz Belardinelli

Technik-/Wissenschafts-/F&E-Leiter bei InCarda Therapeutics, Inc.

Health Technology

Profil

Luiz Belardinelli is currently the Chief Medical Officer at InCarda Therapeutics, Inc. He previously worked as the Senior Vice President-Pharmacology at CV Therapeutics, Inc.

Aktive Positionen von Luiz Belardinelli

Unternehmen	Position	Beginn
InCarda Therapeutics, Inc. InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA.	Technik-/Wissenschafts-/F&E-Leiter	05.04.2016

Alle aktiven Positionen von Luiz Belardinelli

Ehemalige bekannte Positionen von Luiz Belardinelli

Unternehmen	Position	Ende
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Corporate Officer/Principal	02.05.2011

Sehen Sie sich die Erfahrung von Luiz Belardinelli im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Luiz Belardinelli im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Health Technology
InCarda Therapeutics, Inc. InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA.	Health Technology